Clinical Trials Browser

Terminated × INDUSTRY × rilotumumab × Clear all

NCT00791154 2024-08-23

SCLC

Phase 1/2 Terminated

213 enrolled 16 charts

Lung Neoplasms, Pleural Effusion, Malignant, Small Cell Lung Carcinoma

NCT02137343 2016-04-04

RILOMET-2

Phase 3 Terminated

Gastrointestinal

Stomach Neoplasms

NCT01697072 2016-02-09

RILOMET-1

Phase 3 Terminated

Gastrointestinal

Stomach Neoplasms